FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
about
Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort studyFGF23 in Acute and Chronic IllnessThe role of phosphorus in the development and progression of vascular calcificationImmune dysfunction in uremia—an updateFibroblast growth factor 23Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular DiseaseCalcium and phosphate impact cardiovascular risk.FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease.Fibroblast Growth Factor-23-A Potential Uremic ToxinWorsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective studyEvolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.MICS, an easily ignored contributor to arterial calcification in CKD patients.Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney diseasePrognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients.Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patientsMortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients.Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4Soluble klotho may be a marker of phosphate reabsorption.FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts.The use of fibroblast growth factor 23 testing in patients with kidney disease.Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline.Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trialFibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional studyAntibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia.Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.Fibroblast growth factor 23 and incident CKD in type 2 diabetes.Circulating fibroblast growth factor 23 is associated with angiographic severity and extent of coronary artery disease.Fibroblast growth factor 23 and risk of incident stroke in community-living adultsFibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.The impact of acute kidney injury on the long-term risk of stroke.Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.Vitamin D resistance in chronic kidney disease (CKD).
P2860
Q22306543-A4B4F7CF-F8C8-4F1C-9E28-E4032849A46AQ26778554-FA1C52EC-C203-4EEE-9FCF-749E8BBA1015Q26823897-3A6BBFD0-8227-47BC-9C10-C2AE8E8E17B1Q26829076-4CF0A578-9719-43FA-A99B-3EA197CCE2DAQ26829294-FF24EFAE-B190-44A2-8DA4-E70619A016D7Q27024043-4AD2FED9-8DE5-4123-BDF2-30125A32B6A3Q27687570-7224A61A-F522-4476-AF49-D1E955C407B2Q27687769-8418D428-2712-432F-BF19-38F2250006EAQ28075648-81DA5EBE-A1D6-43E3-9C4F-ED6261E8CB63Q28483914-C8208FB8-FFA8-49EC-B42F-D254DB2E1D3FQ30234797-19C3BC72-A4C8-4165-A141-88C2A2CC4CDBQ30249410-A4340B2F-E3D8-4A08-A87D-972BDD03565FQ30658399-477E07DB-B908-4903-A136-FD08D77E73D3Q31171853-7B33934B-7DF7-4814-A76E-9FF6D3B8A22CQ33591588-C08DABD9-B4B0-4D0A-867D-CAA4056D6AC6Q33600110-9DBE32CC-52AE-45BE-8CA3-7844A0D7813CQ33625482-C1A0A112-4F5D-4F6B-934A-5E7C1D5063C6Q33650866-E36C5A68-82DB-485B-BE79-9AFC96DCB188Q33715785-C4431DA3-71E2-4535-AA59-B1DB0D55CEDEQ33783120-62CC3D86-7AB6-4E55-994E-659CF7F5FE30Q33793927-7B418E32-3582-4DF6-A226-1D8411CAB606Q33835743-D275632B-5F7D-4C2B-9819-451533BE4C4BQ33873450-1342D9E6-0F74-49A7-8BD1-21001C886465Q33937415-155727ED-3DBF-4A3B-8715-66A715201A89Q33940724-1422A14D-7285-44A6-9127-C6976A72895EQ34037021-68A320B7-A6E6-4677-863E-6E795223073CQ34054004-F655CE7C-D3E5-4F0A-9C48-1A99037BC190Q34244300-0F4A59C0-9362-49F5-9604-4052433BE136Q34557041-1DC86D83-7CA6-40F3-A42D-25CDEF5B3014Q34603360-EB399EEF-4639-4A49-90DA-E5BB59C51507Q34634066-8EC89B5B-3AB0-4484-BF70-A83CD7995521Q34669005-2E99CA77-949A-4FD9-B031-DD7312634B5EQ34794004-CF64A8F7-4412-41E5-AECF-069A39C43FD0Q34828731-0C5825A4-CF17-49D0-841C-992E4E577F76Q34981550-8FB6EE55-6D45-4D49-B4E0-A6CAFE5DD438Q35019943-125DE89B-5DC3-4D8D-AA1C-24263ABA2A4AQ35021985-9315ACEF-EBC9-489E-9890-14B5C1C261D5Q35026274-ECD7CE66-4D65-4139-B607-C5B12A724A84Q35067500-000602EB-8BE0-43B7-B198-11AC101D48F0Q35123615-F26CA904-6DA0-44B9-BA1D-B7E87BC0AE5F
P2860
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
@ast
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
@en
type
label
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
@ast
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
@en
prefLabel
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
@ast
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
@en
P2093
P2860
P356
P1476
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.
@en
P2093
Alfred K Cheung
Gerard Smits
HOST Investigators
James S Kaufman
Jessica Kendrick
Michel Chonchol
Tom Greene
William L Roberts
P2860
P304
P356
10.1681/ASN.2010121224
P577
2011-09-07T00:00:00Z